MedTrace Logo

Informed Decision Users of the Health System and Participation in Organized Screening for Breast Cancer

NCT02093039 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16000

Last updated 2014-03-20

No results posted yet for this study

Summary

The aim of this study is to assess the impact of a decision aid leaflet on the participation of women invited to participate in the French national breast cancer screening program.

Conditions

Interventions

DEVICE

decision aid group

The paper-based leaflet DECIDEO is a 12-page pocket leaflet providing scientific information about the advantages and disadvantages of participating in the national breast screening program, understandable by all, constructed to conform with the International Patient Decision Aid Standards

Sponsors & Collaborators

  • Institut de Cancérologie de la Loire

    lead OTHER

Principal Investigators

  • Franck CHAUVIN, MDPhD · Institut de Cancérologie Lucien Neuwirth

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02093039 on ClinicalTrials.gov